Of the various immune markers profiled, only A2aR was consistently upregulated in the TIL and glioma-infiltrating myeloid-derived cell (GIM) population relative to PBMCs, including in the PBMCs from healthy donors. The gene discussed is ADORA2A; the disease is glioma.